HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The US Microbead Ban: Are There Teeth, And Would PHAs Pass Through?

This article was originally published in The Rose Sheet

Executive Summary

FDA likely will need to issue guidance to clarify exactly what materials are covered by the ban on plastic microbead use in selected personal-care products – i.e., a definition of “plastic” – and what the consequences of a violation could be. The issue could be of particular relevance to companies exploring gray-area replacement materials such as biodegradable PHA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel